GlassScriptPhysician profile
Janet Raman
NPI 1710958749
$2,560.61
in general payments reported to CMS, 2019-2025
14 companies · $365 in 2025
The $365 reported for 2025 was more than what a typical Adult Health (Nurse Practitioner) provider received nationally (typical 2025 total: $182).
See the full distribution for Adult Health (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $566 · 2023: $581 · 2024: $1,049 · 2025: $365.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,994.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,994.31 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Inspire Medical Systems, INC. | $468.45 | 2023-2025 | Inspire |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $258.13 | 2023-2024 | Caplyta |
| Abbvie INC. | $249.18 | 2022-2023 | |
| Alexion Pharmaceuticals, INC. | $248.47 | 2023-2025 | Koselugo |
| Gilead Sciences, INC. | $246.87 | 2024 | Epclusa, Veklury |
| Janssen Pharmaceuticals, INC | $190.83 | 2022 | |
| Tactile Systems Technology INC | $125.88 | 2022 | |
| Mylan Specialty L.P. | $125.00 | 2024 | Yupelri |
| Viiv Healthcare Company | $125.00 | 2022 | |
| Amgen INC. | $124.99 | 2024 | Repatha |
| Genentech USA, INC. | $121.65 | 2024 | Xolair |
| Shield Therapeutics INC | $107.76 | 2024 | |
| Impel Pharmaceuticals INC. | $87.37 | 2023 | Trudhesa |
| Neurelis, INC. | $81.03 | 2024 | Valtoco |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Janet Raman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.